Oncologist-approved cancer information from the American Society of Clinical Oncology
Printer Friendly
Download PDF

Recommendations

ASCO endorses the following recommendations on ovarian ablation from Cancer Care Ontario:

  • Ovarian ablation should not routinely be used with chemotherapy, tamoxifen, or a combination of these treatments.
  • Ovarian ablation should not be used as an alternative to other treatments, unless a patient is not healthy enough for other treatments or if the patient chooses not to have other treatments.
  • If ovarian ablation is chosen, monthly injections with an LHRH analogue is the best method. (ASCO's endorsement of this recommendation notes that treatment every three months may also be effective.)

© 2005-2012 American Society of Clinical Oncology (ASCO). All rights reserved worldwide.